Skip to Main Content

Paper Details

Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial.
J Clin Oncol
7
2020
Anthracycline, Breast Cancer, Capecitabine, DC, DFS, Docetaxel, PATIENTS, anthracycline, capecitabine, diarrhea, docetaxel, early breast cancer, hand/foot syndrome, leukemia, neuropathy, patients, second cancers, taxanes
Author NameAffiliation
Saskia Liti??re
Laura J Van't VeerHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Florentine S Hilbers
Isabel T RubioClinica Universidad de Navarra-Site Madrid
Gabriele ZoppoliUniversity of Genoa and Azienda Ospedaliera Universitaria San Martino
Gabriele ZoppoliUniversity of Genoa and Azienda Ospedaliera Universitaria San Martino
Konstantinos Tryfonidis
Coralie Poncet
Fatima CardosoChampalimaud Clinical Center/Champalimaud Foundation
  • 1 - 9

Datasets

Release 1.2